pentamidine has been researched along with quinacrine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 7 (43.75) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Chibale, K; Croft, SL; Fairlamb, AH; Haupt, H; Kendrick, H; Saravanamuthu, A; Yardley, V | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Brun, R; Buckner, FS; Chatterjee, AK; Creason, SA; Duster, NA; Gelb, MH; Gillespie, JR; Glynne, R; Hulverson, MA; McQueen, J; Molteni, V; Nagendar, P; Nagle, A; Norcross, NR; Ranade, RM; Supek, F; Tatipaka, HB; Wenzler, T | 1 |
Barros-Álvarez, X; Buckner, FS; Creason, SA; Fan, E; Gillespie, JR; Hol, WGJ; Huang, W; Koh, CY; Ranade, RM; Shibata, S; Verlinde, CLMJ; Zhang, Z | 1 |
Buckner, FS; Gelb, MH; Gillespie, JR; Herbst, ZM; Montanari, CA; Nguyen, UTT; Ranade, RM; Silva, DG | 1 |
Buckner, FS; Faghih, O; Gelb, MH; Gillespie, JR; Herbst, ZM; Molasky, NMR; Nagendar, P; Ranade, RM; Turner, RM | 1 |
Barros-Álvarez, X; Buckner, FS; Choy, RKM; de Hostos, E; Faghih, O; Fan, E; Gillespie, JR; Hol, WGJ; Huang, W; Molasky, NMR; Mushtaq, A; Ranade, RM; Shibata, S; Verlinde, CLMJ; Zhang, Z | 1 |
Mattock, NM; Peters, W | 1 |
Musil, R; Wachtler, F | 1 |
Chan, KF; Chan, TH; Chow, LM; Wong, IL; Zhao, Y | 1 |
16 other study(ies) available for pentamidine and quinacrine
Article | Year |
---|---|
Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine.
Topics: Animals; Antiprotozoal Agents; Leishmania; Parasitic Sensitivity Tests; Plasmodium; Quinacrine; Sulfonamides; Trypanosoma; Urea | 2001 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis.
Topics: Administration, Oral; Animals; Biological Availability; Cell Line, Tumor; Cell Membrane Permeability; Databases, Chemical; Dogs; Female; Humans; Imidazoles; Madin Darby Canine Kidney Cells; Mice; Microsomes, Liver; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2014 |
Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitors.
Topics: Animals; Brain; Chemistry Techniques, Synthetic; Drug Design; Enzyme Inhibitors; Hep G2 Cells; Humans; Methionine-tRNA Ligase; Mice; Permeability; Protein Conformation; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2016 |
New Class of Antitrypanosomal Agents Based on Imidazopyridines.
Topics: | 2017 |
Triazolopyrimidines and Imidazopyridines: Structure-Activity Relationships and in Vivo Efficacy for Trypanosomiasis.
Topics: | 2019 |
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against
Topics: | 2020 |
The experimental chemotherapy of leishmaniasis. II. The activity in tissue culture of some antiparasitic and antimicrobial compounds in clinical use.
Topics: Aminoquinolines; Animals; Anti-Bacterial Agents; Antimalarials; Antimony; Antiprotozoal Agents; Ascitic Fluid; Cell Line; Chloroquine; Cricetinae; Culture Techniques; Dogs; Drug Evaluation, Preclinical; Folic Acid Antagonists; Leishmania; Niridazole; Pentamidine; Primaquine; Quinacrine; Quinine; Sarcoma; Sulfonamides; Sulfones; Suramin | 1975 |
On the structure and polymorphism of the human chromosome no. 15.
Topics: Chromosome Banding; Chromosomes, Human, 13-15; Humans; Pentamidine; Plicamycin; Polymorphism, Genetic; Quinacrine; Silver; Staining and Labeling | 1980 |
Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania.
Topics: Animals; Antiprotozoal Agents; Apigenin; Drug Resistance; Drug Synergism; Inhibitory Concentration 50; Leishmania donovani; Leishmania enriettii; Pentamidine; Quinacrine | 2009 |